Letter of Intent

71-75 Shelton Street, Covent Garden

Ladies and Gentlemen:

Following our recent discussions, this letter

will confirm that Enochian BioSciences Inc., a Delaware corporation ("Enochian") is interested in acquiring

GEDi Cube Intl Ltd (the "Company") (the "Potential Transaction"). In this letter,

the Company and Enochian are referred to as "Party" or "Parties".

The Company has novel, advanced life science

Artificial Intelligence (AI)/Large Language Model (LLM) that could potentially be used to diagnosis diseases, predict responses

to treatments and help design more effective therapies. Enochian is a cell- gene- immunotherapy company with a potential product

to treat solid tumors starting with cancers with limited treatment options and a poor life expectancy. Enochian believes it could

be at the human study phased by the mid- to late-2024. The combination of advanced AI/LLM with therapeutic research and development

with access to data from humans could potentially accelerate the capabilities of the AI technology while potentially driving better

diagnosis and treatment of cancers and other diseases.

1. Material Terms. The material terms

will be as set forth on the non-binding Term Sheet set forth as Annex A hereto.

The parties, intending to be legally bound,

agree to the following legally enforceable paragraphs of this letter (the "Binding Provisions").

2. Access. Upon execution of this

letter, each Party will afford the other Party, and each of their duly authorized representatives, immediate full and free access

to the other Party, its personnel, properties, contracts, books and records, and all other documents and data necessary to complete

due diligence, subject to the Confidential Disclosure Agreement entered into between the Company and Enochian on July 17, 2023

3. Exclusive Dealing

4. Conduct Of Business. Other than

the payment of expenses necessary to consummate the Potential Transaction contemplated hereby, the Company shall operate in the

ordinary course and refrain from any transactions outside the ordinary course of business.

5. Confidentiality. Prior to the

closing of the Potential Transaction, the Company will not, except as otherwise required by law, without the written consent of

Enochian, make any announcement about the Potential Transaction to the Company's customers, suppliers, or employees, or to

any other person or entity, or otherwise disclose the existence of this letter, the existence of the discussions among the parties

concerning the Potential Transaction or the specific terms of this letter. The parties will cooperate with one another in good

faith in making a joint public announcement of the existence of the Potential Transaction, if legally necessary. Except as expressly

modified herein, all other confidentiality agreements entered into between the Company and Enochian, including but not limited

to the NDA, shall remain in full force and effect.

6. Costs. Except as provided for

in the Purchase Agreement, each Party will be responsible for and bear all of its respective costs and expenses incurred at any

time in connection with pursuing or consummating the Potential Transaction.

7. Termination. The Binding Provisions

will automatically terminate upon the earliest of the following (the "Termination Date"): (i) expiration of

the Exclusivity Period; (ii) execution of the Purchase Agreement by all parties thereto; or (iii) the mutual written agreement

of Enochian and the Company; provided, however, that the termination of the Binding Provisions will not affect the liability of

a Party for breach of any of the Binding Provisions prior to the termination. Upon termination of the Binding Provisions, the Parties

will have no further obligations under this letter except that Paragraphs 5 and 9 will survive such termination.

8. Effect of Letter. The Term Sheet

attached to this letter is intended only as an expression of interest on behalf of Enochian, is not intended to be legally binding

on any party, and is expressly subject to the negotiation and execution of an appropriate Purchase Agreement. In addition, nothing

in this letter should be construed as an offer or commitment on the part of Enochian to submit a definitive proposal concerning

the Potential Transaction. Except as expressly provided in Paragraphs 2 through 9 (or as expressly provided in any binding written

agreement that the Parties may enter into in the future), no past or future action, course of conduct, or failure to act relating

to the Potential Transaction, or relating to the negotiation of the terms of the Purchase Agreement, will give rise to or serve

as a basis for any obligation or other liability on the part of the Parties.

If you are in agreement with the foregoing,

please sign and return one copy of this letter, which thereupon will constitute our understanding with respect to its subject matter

and a binding agreement with respect to the Binding Provisions.

Accepted and agreed: